Nexium 40mg is a prescription medication used to treat acid reflux disease (GERD), heartburn, and acid regurgitation. It belongs to a group of medications called proton pump inhibitors (PPIs), which are used to relieve some of the symptoms of gastroesophageal reflux disease (GERD) such as swallowing acid.
Proton pump inhibitors (PPIs) are used to treat GERD by reducing stomach acid production. They are commonly prescribed by doctors for moderate to severe stomach problems. Nexium 40mg works by reducing the acid in the stomach's lining, causing the food to feel fuller and more food full, which reduces the amount of stomach acid needed for digestion.
Nexium 40mg should be taken orally with a full glass of water. It can be taken with or without food. Follow your doctor's instructions about the timing of the dose and how often you should take it. Take Nexium 40mg exactly as directed, and it will help you to feel better. Do not skip any dose or stop taking the medication immediately without talking with your doctor, even if you feel well.
It is important to follow your doctor's instructions about the timing of the dose and how often you should take it. Do not take more than one dose within a 24-hour period, and keep taking it even if you feel well. Do not stop the medication without talking with your doctor, even if you are feeling better.
The dosage of Nexium 40mg depends on the condition you are being treated for and your body’s response to the medication. The usual starting dose is 20-40 mg once daily, taken orally once daily. The dosage may be increased to 60-80 mg once daily based on your response and tolerance to the medication.
The most common dosage instructions are:
Some of the most common side effects of Nexium 40mg are:
Serious side effects can include an increased risk of acid reflux, heart problems, sudden vision or hearing loss, and an increased risk of developing a condition called primary dysmenorrhea. If you experience any of these symptoms, stop taking Nexium and contact your doctor right away.
If you are allergic to esomeprazole or any of the ingredients in Nexium 40mg tablets, read the label carefully. If you have heartburn or acid regurgitation (also known as regurgitation of stomach acid), take Nexium as directed. Do not take Nexium if you are having surgery, including dental surgery.
Symptoms of an allergic reaction include a rash, itching, trouble breathing, swelling of the face, lips, or throat, or difficulty swallowing. If you are allergic to any other medications, do not take Nexium.
Nexium® 24HR 20mg Mini Capsules provide lasting relief from frequent heartburn and acid reflux in a 53% smaller capsule (based on volume of the capsule vs Nexium® 24HR Once Daily Dosing Tablet)
Nexium 24 Hour Once Daily Dosing provides lasting relief for frequent heartburn & acid reflux.
Boxed Contents: 14 Mini Capsules Size: 14 Mini Capsules
Do not use:
CAUTION Always read the label. Follow the directions for use.
Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Active Ingredients: Each capsule contains Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Adults 18 years, of age and over: Take 1 capsule daily for at least 7 days and up to 14 days.
Swallow the capsule whole with water, with or without food. Do not crush, chew or open the capsule. Not intended for immediate relief. It may take a few days to achieve maximum results.
Do not take for more than 14 days unless directed by a doctor.
USAGE ADVICE The bottle contains a sealed container with silica gel desiccant. Keep the bottle tightly closed to protect from moisture.
SAFETY DIRECTIONS
Carefully read the enclosed leaflet before use.
Ask your doctor or pharmacist before use if you:
STORAGE INSTRUCTIONS Store below 25°C in a cool, dry place. Storage Temperature: Below 25°C.
Substance(s)This medication contains sucrose. Sublimation is not recommended if you are sub-optimized. When stalling side effects are experienced. Sublimation does not protect from sub-optimal doses. Sublimation usually occurs in response to stress and is not serious. Check your doctor instructions.Active Ingredients: Esomeprazole magnesium trihydrate 22.3mg (equivalent to esomeprazole 20mg)
Other Name Substance: Colestipol 500 mg, Colestipol 600 mg, Colestipol 10 mg, Phenytoin 500 mg, Transt LM 575 mg, Zoloft 50 mg
Contains sucrose. Sublimation is not recommended if you are sub-limed.Inform your doctor if you:
General Product DescriptionNexium 24HR Once Daily Dosing Tablets provide lasting relief from frequent heartburn and acid reflux. They providelasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux.
Key Features
Directions For UseAdults 18 years of age and over:Take 1 tablet daily for at least 7 days and up to 14 days. Swallow the tablet whole with water, with or without food. Do not crush or chew the tablet. Do not take for more than 14 days unless drected byt a doctor.Not intended for immediate relief. It may take a few days to achieve maximum results.
WarningsAlways read and follow the directions before use. If symptoms persist, disconinue use and consult your healthcare professional. Keep out of reach of children. Do not use if you are pregnant or breast feeding, or under the age of 18.
IngredientsEach tablet contains: Esomeprazole 20mg (as Magnesium Trihydrate).
criptionsAUST R NUMBER: EGYROGY Recommended
Prescription only medicine and use as advised without knowing your national or health insurance details.
Do not give this medication to anyone less than 18 years old.
«ShareYou can keep more than 99% of your favourite brands of prescription medicines in your own section.
Read more aboutAlways read the label.
You can keep more than 99% of your favourite brands of prescription medicines without ever having any medical advice.
You can share your order with others. They can translate your order quantity to their own pages and send it to your door.
NEW YORK — In the wake of the recent death of the US president’s son from a heart attack and his sudden inability to sleep, the Food and Drug Administration said the generic version of AstraZeneca’s blockbuster anti-heartburn drug will be available at pharmacies nationwide.
“The agency is working with pharmacies to ensure that consumers can access the generic version of AstraZeneca’s AstraZeneca drug, and that this will be available to patients for a period of three years,” the FDA said.
The generic form of the drug, Nexium, will be available in pharmacies in the United States. It will cost $4 a pill.
AstraZeneca said it plans to start marketing the generic version in November in an attempt to sell its anti-acid drug.
The company said its “marketing and supply chain strategy will include a focus on patient safety, quality assurance and patient satisfaction,” and will work with its pharmacists and physicians to identify and select the best option.
The FDA said it is committed to keeping a close eye on the company’s drug’s effectiveness and minimizing any potential harm to consumers who are taking the drug.
In addition to the generic, the agency said it has worked with other drugmakers and pharmacies to ensure that the drug remains available and that pharmacies receive a free prescription from the manufacturer for use.
The FDA said it is working with the FDA to ensure the safety of the drug and its availability to consumers.
“As part of this program, the FDA will monitor and analyze and report to its public the safety and efficacy of the generic drug,” the FDA said in a press release. “This includes informing consumers about its use and potential risks and also ensuring that they receive the same therapeutic benefits that are supported by the generic form of AstraZeneca’s drug, Nexium.”
AstraZeneca said it is committed to working closely with the FDA to monitor the effectiveness of the drug and to minimize any potential harm it may cause.
The company said it is working with other drugmakers to ensure that the drug remains available and that pharmacies receive a free prescription for use. It is also working with its pharmacists and physicians to identify and select the best option.
“The FDA has identified a number of potential risks and is taking steps to minimize these risks and to ensure that the availability of this generic drug remains available,” said Michael J. Schwartz, director of the FDA’s Center for Drug Evaluation and Research. “We are taking steps to ensure that the availability of this generic drug remains available.”
AstraZeneca said it is working with other drugmakers to ensure the safety of the drug and to minimize any potential harm it may cause. AstraZeneca said it is working with the FDA to monitor and evaluate the effectiveness of the drug and to ensure that pharmacies are receiving a free prescription for use.The company said it will provide a copy of the FDA’s public announcement with each of its letters from pharmaceutical company officials and representatives on the company’s website.
“This information is for educational purposes only and should not be considered medical advice,” the agency said in a press release. “The FDA’s statements, however, are intended for educational purposes only and should not be considered medical advice.”
Originally Published: August 4, 2013 at 8:00 AM EDT
FDA released a statement saying that “the Agency is committed to ensuring that patients and prescribers receive the best possible care when taking AstraZeneca’s AstraZeneca Antacid product.”‘We are pleased to have received your letter of inquiry from the FDA. We are in the process of getting the FDA to add this important letter to its website. Our goal is to provide information that helps consumers make informed decisions about their health and well-being.’The FDA said it will update its website in the future as more information becomes available.
The letter, from a senior FDA official, will reflect the information the agency will have on AstraZeneca’s drug and will provide an opportunity to comment on the information, including whether it is a safe and effective treatment for AstraZeneca’s allergy-related patients. The agency will also update its website on AstraZeneca’s Antacid and related products.
The agency said it is working with the FDA to notify pharmacies of the information it will provide and will contact them within 45 days of the first post office box notification.
Stade de France Pharmacy